PMID- 32605626 OWN - NLM STAT- MEDLINE DCOM- 20201214 LR - 20201214 IS - 1757-7241 (Electronic) IS - 1757-7241 (Linking) VI - 28 IP - 1 DP - 2020 Jun 30 TI - Resuscitative endovascular balloon occlusion of the aorta may contribute to improved survival. PG - 62 LID - 10.1186/s13049-020-00757-2 [doi] LID - 62 AB - BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is an increasingly used trauma resuscitation procedure, however, there are no reports of whether or not the survival of patients treated with REBOA increases over time. METHODS: This retrospective cohort study from a nationwide trauma registry in Japan was conducted between 2004 and 2015. Patients treated with REBOA were divided into three calendar year periods: early-period (2004-2007), mid-period (2008-2011), and late-period (2012-2015). The primary outcome of in-hospital survival was compared between the periods (early-period: reference) using mixed effects logistic regression analysis after adjustment for characteristics, trauma severity, and therapeutic choices. RESULTS: Of 236,698 trauma patients, 633 patients treated with REBOA were analyzed. Distribution of the patients across periods was as follows: early-period (91), mid-period (276), and late-period (266). In-hospital survival was 39, 49, and 60% in the early-period, mid-period, and late-period, respectively. In regression modeling, the late-period (OR = 2.976, 95% CI = 1.615-5.482) was associated with improved in-hospital survival compared to the early-period, however, the mid-period (OR = 1.614, 95% CI = 0.898-2.904) was not associated with improved survival. CONCLUSIONS: Survival of patients treated with REBOA during the late-period improved compared with survival during the early-period, after adjustment for characteristics, trauma severity, and therapeutic choices. REBOA may be one of the important factors related to progression of modern trauma treatment. FAU - Aoki, Makoto AU - Aoki M AUID- ORCID: 0000-0001-8239-8822 AD - Department of Emergency Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan. aokimakoto@gunma-u.ac.jp. FAU - Abe, Toshikazu AU - Abe T AD - Department of General Medicine, Juntendo University, Tokyo, Japan. AD - Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan. FAU - Hagiwara, Shuichi AU - Hagiwara S AD - Department of Emergency Medicine, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan. FAU - Saitoh, Daizoh AU - Saitoh D AD - Department of Traumatology and Emergency Medicine, National Defense Medical College, Tokorozawa, Japan. FAU - Oshima, Kiyohiro AU - Oshima K AD - Department of Emergency Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan. LA - eng PT - Journal Article PT - Multicenter Study DEP - 20200630 PL - England TA - Scand J Trauma Resusc Emerg Med JT - Scandinavian journal of trauma, resuscitation and emergency medicine JID - 101477511 SB - IM MH - Adult MH - Aged MH - Aorta, Thoracic/*surgery MH - Balloon Occlusion/*methods MH - Endovascular Procedures/*methods MH - Female MH - Humans MH - Japan/epidemiology MH - Male MH - Middle Aged MH - *Registries MH - Resuscitation/*methods MH - Retrospective Studies MH - Shock, Hemorrhagic/etiology/mortality/*therapy MH - Survival Rate/trends MH - Wounds and Injuries/complications/mortality/*surgery PMC - PMC7325257 OTO - NOTNLM OT - Japan OT - Logistic models OT - Mortality trend OT - Resuscitative endovascular balloon occlusion of the aorta (REBOA) OT - Trauma COIS- The authors declare that they have no competing interests. EDAT- 2020/07/02 06:00 MHDA- 2020/12/15 06:00 PMCR- 2020/06/30 CRDT- 2020/07/02 06:00 PHST- 2019/11/14 00:00 [received] PHST- 2020/06/24 00:00 [accepted] PHST- 2020/07/02 06:00 [entrez] PHST- 2020/07/02 06:00 [pubmed] PHST- 2020/12/15 06:00 [medline] PHST- 2020/06/30 00:00 [pmc-release] AID - 10.1186/s13049-020-00757-2 [pii] AID - 757 [pii] AID - 10.1186/s13049-020-00757-2 [doi] PST - epublish SO - Scand J Trauma Resusc Emerg Med. 2020 Jun 30;28(1):62. doi: 10.1186/s13049-020-00757-2.